123 related articles for article (PubMed ID: 1386112)
1. Preferred antagonist binding state of the NMDA receptor: synthesis, pharmacology, and computer modeling of (phosphonomethyl)phenylalanine derivatives.
Dorville A; McCort-Tranchepain I; Vichard D; Sather W; Maroun R; Ascher P; Roques BP
J Med Chem; 1992 Jul; 35(14):2551-62. PubMed ID: 1386112
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity analysis of binding kinetics for NMDA receptor competitive antagonists: the influence of conformational restriction.
Benveniste M; Mayer ML
Br J Pharmacol; 1991 Sep; 104(1):207-21. PubMed ID: 1686203
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and pharmacology of a series of 3- and 4-(phosphonoalkyl)pyridine- and -piperidine-2-carboxylic acids. Potent N-methyl-D-aspartate receptor antagonists.
Ornstein PL; Schaus JM; Chambers JW; Huser DL; Leander JD; Wong DT; Paschal JW; Jones ND; Deeter JB
J Med Chem; 1989 Apr; 32(4):827-33. PubMed ID: 2539478
[TBL] [Abstract][Full Text] [Related]
4. Potent, orally active, competitive N-methyl-D-aspartate (NMDA) receptor antagonists are substrates for a neutral amino acid uptake system in Chinese hamster ovary cells.
Li JH; Bigge CF; Williamson RM; Borosky SA; Vartanian MG; Ortwine DF
J Med Chem; 1995 May; 38(11):1955-65. PubMed ID: 7783127
[TBL] [Abstract][Full Text] [Related]
5. Pharmacology of ACEA-1416: a potent systemically active NMDA receptor glycine site antagonist.
Ilyin VI; Whittemore ER; Tran M; Shen KZ; Cai SX; Kher SM; Keana JF; Weber E; Woodward RM
Eur J Pharmacol; 1996 Aug; 310(2-3):107-14. PubMed ID: 8884205
[TBL] [Abstract][Full Text] [Related]
6. Analogs of 3-hydroxy-1H-1-benzazepine-2,5-dione: structure-activity relationship at N-methyl-D-aspartate receptor glycine sites.
Guzikowski AP; Cai SX; Espitia SA; Hawkinson JE; Huettner JE; Nogales DF; Tran M; Woodward RM; Weber E; Keana JF
J Med Chem; 1996 Nov; 39(23):4643-53. PubMed ID: 8917653
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of 1,4,7,8,9,10-hexahydro-9-methyl-6-nitropyrido[3,4-f]- quinoxaline-2,3-dione and related quinoxalinediones: characterization of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (and N-methyl-D-aspartate) receptor and anticonvulsant activity.
Bigge CF; Malone TC; Boxer PA; Nelson CB; Ortwine DF; Schelkun RM; Retz DM; Lescosky LJ; Borosky SA; Vartanian MG
J Med Chem; 1995 Sep; 38(19):3720-40. PubMed ID: 7562904
[TBL] [Abstract][Full Text] [Related]
8. 4-Amido-2-carboxytetrahydroquinolines. Structure-activity relationships for antagonism at the glycine site of the NMDA receptor.
Leeson PD; Carling RW; Moore KW; Moseley AM; Smith JD; Stevenson G; Chan T; Baker R; Foster AC; Grimwood S
J Med Chem; 1992 May; 35(11):1954-68. PubMed ID: 1534584
[TBL] [Abstract][Full Text] [Related]
9. 3-Nitro-3,4-dihydro-2(1H)-quinolones. Excitatory amino acid antagonists acting at glycine-site NMDA and (RS)-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors.
Carling RW; Leeson PD; Moore KW; Smith JD; Moyes CR; Mawer IM; Thomas S; Chan T; Baker R; Foster AC
J Med Chem; 1993 Oct; 36(22):3397-408. PubMed ID: 8230130
[TBL] [Abstract][Full Text] [Related]
10. Characterization of 3-carboxy-5-phosphono-1,2,3,4-tetrahydroisoquinoline (SC-48981), a potent competitive N-methy-D-aspartate (NMDA) receptor antagonist, in vitro and in vivo.
Vazquez ML; Garland DJ; Sun ET; Cler JA; Mick SJ; Hood WF; Monahan JB; Iyengar S; Rao TS
Neurosci Lett; 1992 Feb; 135(2):149-52. PubMed ID: 1352628
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, preliminary evaluation and molecular modeling studies of new, conformationally constrained analogues of the competitive NMDA receptor antagonist 4-(phosphonomethyl)-2-piperidinecarboxylic acid (CGS 19755).
Pellicciari R; Marinozzi M; Natalini B; Costantino G; Lankin DC; Snyder JP; Monahan JB
Farmaco; 1997; 52(6-7):477-86. PubMed ID: 9490080
[TBL] [Abstract][Full Text] [Related]
12. Generation of N-methyl-D-aspartate agonist and competitive antagonist pharmacophore models. Design and synthesis of phosphonoalkyl-substituted tetrahydroisoquinolines as novel antagonists.
Ortwine DF; Malone TC; Bigge CF; Drummond JT; Humblet C; Johnson G; Pinter GW
J Med Chem; 1992 Apr; 35(8):1345-70. PubMed ID: 1533422
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and structure-activity studies of N,N'-diarylguanidine derivatives. N-(1-naphthyl)-N'-(3-ethylphenyl)-N'-methylguanidine: a new, selective noncompetitive NMDA receptor antagonist.
Reddy NL; Hu LY; Cotter RE; Fischer JB; Wong WJ; McBurney RN; Weber E; Holmes DL; Wong ST; Prasad R
J Med Chem; 1994 Jan; 37(2):260-7. PubMed ID: 8295213
[TBL] [Abstract][Full Text] [Related]
14. Exploration of phenyl-spaced 2-amino-(5-9)-phosphonoalkanoic acids as competitive N-methyl-D-aspartic acid antagonists.
Bigge CF; Drummond JT; Johnson G; Malone T; Probert AW; Marcoux FW; Coughenour LL; Brahce LJ
J Med Chem; 1989 Jul; 32(7):1580-90. PubMed ID: 2544728
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and pharmacological evaluation of 4a-phenanthrenamine derivatives acting at the phencyclidine binding site of the N-methyl-D-aspartate receptor complex.
Bigge CF; Malone TC; Hays SJ; Johnson G; Novak PM; Lescosky LJ; Retz DM; Ortwine DF; Probert AW; Coughenour LL
J Med Chem; 1993 Jul; 36(14):1977-95. PubMed ID: 8336337
[TBL] [Abstract][Full Text] [Related]
16. Kynurenic acid analogues with improved affinity and selectivity for the glycine site on the N-methyl-D-aspartate receptor from rat brain.
Foster AC; Kemp JA; Leeson PD; Grimwood S; Donald AE; Marshall GR; Priestley T; Smith JD; Carling RW
Mol Pharmacol; 1992 May; 41(5):914-22. PubMed ID: 1375317
[TBL] [Abstract][Full Text] [Related]
17. Syntheses, activity and modeling studies of 3- and 4-(sulfo- and sulfonamidoalkyl)pyridine and piperidine-2-carboxylic acid derivatives as analogs of NMDA receptor antagonists.
el Hadri A; Maldivi P; Leclerc G; Rocher JP
Bioorg Med Chem; 1995 Sep; 3(9):1183-201. PubMed ID: 8564410
[TBL] [Abstract][Full Text] [Related]
18. Characterization of indole-2-carboxylate derivatives as antagonists of N-methyl-D-aspartate receptor activity at the associated glycine recognition site.
Hood WF; Gray NM; Dappen MS; Watson GB; Compton RP; Cordi AA; Lanthorn TH; Monahan JB
J Pharmacol Exp Ther; 1992 Aug; 262(2):654-60. PubMed ID: 1386886
[TBL] [Abstract][Full Text] [Related]
19. In vitro pharmacology of ACEA-1021 and ACEA-1031: systemically active quinoxalinediones with high affinity and selectivity for N-methyl-D-aspartate receptor glycine sites.
Woodward RM; Huettner JE; Guastella J; Keana JF; Weber E
Mol Pharmacol; 1995 Mar; 47(3):568-81. PubMed ID: 7700254
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and pharmacological evaluation of N-(2,5-disubstituted phenyl)-N'-(3-substituted phenyl)-N'-methylguanidines as N-methyl-D-aspartate receptor ion-channel blockers.
Hu LY; Guo J; Magar SS; Fischer JB; Burke-Howie KJ; Durant GJ
J Med Chem; 1997 Dec; 40(26):4281-9. PubMed ID: 9435897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
